Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era
Since the introduction of highly active antiretroviral therapy, the life span of people with human immunodeficiency virus (HIV) or AIDS (PWHA) has been extended significantly. Therefore, the importance of non-AIDS-defining cancers (NADCs), as well as AIDS-defining cancers (ADCs) has increased. There...
Saved in:
Published in | Journal of Korean medical science Vol. 32; no. 9; pp. 1445 - 1450 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Academy of Medical Sciences
01.09.2017
대한의학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1011-8934 1598-6357 1598-6357 |
DOI | 10.3346/jkms.2017.32.9.1445 |
Cover
Abstract | Since the introduction of highly active antiretroviral therapy, the life span of people with human immunodeficiency virus (HIV) or AIDS (PWHA) has been extended significantly. Therefore, the importance of non-AIDS-defining cancers (NADCs), as well as AIDS-defining cancers (ADCs) has increased. There is little information concerning the epidemiology of malignancies in PWHA in Korea. A descriptive epidemiologic study was conducted at a tertiary care hospital in Korea. PWHA who visited Pusan National University Hospital from January 2000 to October 2014 were included. Demographics and clinical data were obtained from the medical records and analyzed. A total of 950 PWHA were observed for 4,439.71 person-years. Forty-eight episodes (5.05%) of cancers were diagnosed in 47 patients. Mean age of the enrolled patients was 40.66 ± 12.15 years and 88% were male. Among the 48 cancer episodes, 20 (42%) were ADCs and 28 were NADCs. The most common ADCs was non-Hodgkin's lymphoma (53.6%), followed by Kaposi's sarcoma (17.9%). The most common NADCs were lung cancer (25%) and hepatocellular carcinoma (25%). The overall incidence of total cancers, ADCs, and NADCs was 10.8 (95% confidence interval [CI], 8.0-14.3), 4.5 (95% CI, 2.8-7.0), and 6.3 (95% CI, 4.2-9.1)/1,000 person-years, respectively. NADCs accounted for 12/15 (80%) of cancers among PWHA with good adherence to care. The 5-year survival rate of PWHA and NADC was 26.3%. NADCs have become the main type of malignancy among Korean PWHA with good adherence to care. Effective strategies to improve screening of NADCs among PWHA are required in Korea. |
---|---|
AbstractList | Since the introduction of highly active antiretroviral therapy, the life span of people with human immunodeficiency virus (HIV) or AIDS (PWHA) has been extended significantly. Therefore, the importance of non-AIDS-defining cancers (NADCs), as well as AIDS-defining cancers (ADCs) has increased. There is little information concerning the epidemiology of malignancies in PWHA in Korea. A descriptive epidemiologic study was conducted at a tertiary care hospital in Korea. PWHA who visited Pusan National University Hospital from January 2000 to October 2014 were included. Demographics and clinical data were obtained from the medical records and analyzed. A total of 950 PWHA were observed for 4,439.71 person-years. Forty-eight episodes (5.05%) of cancers were diagnosed in 47 patients. Mean age of the enrolled patients was 40.66 ± 12.15 years and 88% were male. Among the 48 cancer episodes, 20 (42%) were ADCs and 28 were NADCs. The most common ADCs was non-Hodgkin's lymphoma (53.6%), followed by Kaposi's sarcoma (17.9%). The most common NADCs were lung cancer (25%) and hepatocellular carcinoma (25%). The overall incidence of total cancers, ADCs, and NADCs was 10.8 (95% confidence interval [CI], 8.0-14.3), 4.5 (95% CI, 2.8-7.0), and 6.3 (95% CI, 4.2-9.1)/1,000 person-years, respectively. NADCs accounted for 12/15 (80%) of cancers among PWHA with good adherence to care. The 5-year survival rate of PWHA and NADC was 26.3%. NADCs have become the main type of malignancy among Korean PWHA with good adherence to care. Effective strategies to improve screening of NADCs among PWHA are required in Korea. Since the introduction of highly active antiretroviral therapy, the life span of people with human immunodeficiency virus (HIV) or AIDS (PWHA) has been extended significantly. Therefore, the importance of non-AIDS-defining cancers (NADCs), as well as AIDS-defining cancers (ADCs) has increased. There is little information concerning the epidemiology of malignancies in PWHA in Korea. A descriptive epidemiologic study was conducted at a tertiary care hospital in Korea. PWHA who visited Pusan National University Hospital from January 2000 to October 2014 were included. Demographics and clinical data were obtained from the medical records and analyzed. A total of 950 PWHA were observed for 4,439.71 person-years. Forty-eight episodes (5.05%) of cancers were diagnosed in 47 patients. Mean age of the enrolled patients was 40.66 ± 12.15 years and 88% were male. Among the 48 cancer episodes, 20 (42%) were ADCs and 28 were NADCs. The most common ADCs was non-Hodgkin's lymphoma (53.6%), followed by Kaposi's sarcoma (17.9%). The most common NADCs were lung cancer (25%) and hepatocellular carcinoma (25%). The overall incidence of total cancers, ADCs, and NADCs was 10.8 (95% confidence interval [CI], 8.0–14.3), 4.5 (95% CI, 2.8–7.0), and 6.3 (95% CI, 4.2–9.1)/1,000 person-years, respectively. NADCs accounted for 12/15 (80%) of cancers among PWHA with good adherence to care. The 5-year survival rate of PWHA and NADC was 26.3%. NADCs have become the main type of malignancy among Korean PWHA with good adherence to care. Effective strategies to improve screening of NADCs among PWHA are required in Korea. KCI Citation Count: 0 Since the introduction of highly active antiretroviral therapy, the life span of people with human immunodeficiency virus (HIV) or AIDS (PWHA) has been extended significantly. Therefore, the importance of non-AIDS-defining cancers (NADCs), as well as AIDS-defining cancers (ADCs) has increased. There is little information concerning the epidemiology of malignancies in PWHA in Korea. A descriptive epidemiologic study was conducted at a tertiary care hospital in Korea. PWHA who visited Pusan National University Hospital from January 2000 to October 2014 were included. Demographics and clinical data were obtained from the medical records and analyzed. A total of 950 PWHA were observed for 4,439.71 person-years. Forty-eight episodes (5.05%) of cancers were diagnosed in 47 patients. Mean age of the enrolled patients was 40.66 ± 12.15 years and 88% were male. Among the 48 cancer episodes, 20 (42%) were ADCs and 28 were NADCs. The most common ADCs was non-Hodgkin's lymphoma (53.6%), followed by Kaposi's sarcoma (17.9%). The most common NADCs were lung cancer (25%) and hepatocellular carcinoma (25%). The overall incidence of total cancers, ADCs, and NADCs was 10.8 (95% confidence interval [CI], 8.0-14.3), 4.5 (95% CI, 2.8-7.0), and 6.3 (95% CI, 4.2-9.1)/1,000 person-years, respectively. NADCs accounted for 12/15 (80%) of cancers among PWHA with good adherence to care. The 5-year survival rate of PWHA and NADC was 26.3%. NADCs have become the main type of malignancy among Korean PWHA with good adherence to care. Effective strategies to improve screening of NADCs among PWHA are required in Korea.Since the introduction of highly active antiretroviral therapy, the life span of people with human immunodeficiency virus (HIV) or AIDS (PWHA) has been extended significantly. Therefore, the importance of non-AIDS-defining cancers (NADCs), as well as AIDS-defining cancers (ADCs) has increased. There is little information concerning the epidemiology of malignancies in PWHA in Korea. A descriptive epidemiologic study was conducted at a tertiary care hospital in Korea. PWHA who visited Pusan National University Hospital from January 2000 to October 2014 were included. Demographics and clinical data were obtained from the medical records and analyzed. A total of 950 PWHA were observed for 4,439.71 person-years. Forty-eight episodes (5.05%) of cancers were diagnosed in 47 patients. Mean age of the enrolled patients was 40.66 ± 12.15 years and 88% were male. Among the 48 cancer episodes, 20 (42%) were ADCs and 28 were NADCs. The most common ADCs was non-Hodgkin's lymphoma (53.6%), followed by Kaposi's sarcoma (17.9%). The most common NADCs were lung cancer (25%) and hepatocellular carcinoma (25%). The overall incidence of total cancers, ADCs, and NADCs was 10.8 (95% confidence interval [CI], 8.0-14.3), 4.5 (95% CI, 2.8-7.0), and 6.3 (95% CI, 4.2-9.1)/1,000 person-years, respectively. NADCs accounted for 12/15 (80%) of cancers among PWHA with good adherence to care. The 5-year survival rate of PWHA and NADC was 26.3%. NADCs have become the main type of malignancy among Korean PWHA with good adherence to care. Effective strategies to improve screening of NADCs among PWHA are required in Korea. |
Author | Kang, Jin Suk Lee, Jeong Eun Lee, Sun Hee Lee, Seung Geun Chung, Joo Seop Lee, Shinwon Kwak, Ihm Soo |
AuthorAffiliation | Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea |
AuthorAffiliation_xml | – name: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea |
Author_xml | – sequence: 1 givenname: Shinwon orcidid: 0000-0001-7652-7093 surname: Lee fullname: Lee, Shinwon organization: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea – sequence: 2 givenname: Sun Hee orcidid: 0000-0003-2093-3628 surname: Lee fullname: Lee, Sun Hee organization: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea – sequence: 3 givenname: Jeong Eun orcidid: 0000-0003-3027-1381 surname: Lee fullname: Lee, Jeong Eun organization: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea – sequence: 4 givenname: Jin Suk orcidid: 0000-0002-4137-5453 surname: Kang fullname: Kang, Jin Suk organization: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea – sequence: 5 givenname: Seung Geun orcidid: 0000-0002-5205-3978 surname: Lee fullname: Lee, Seung Geun organization: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea – sequence: 6 givenname: Joo Seop orcidid: 0000-0001-7008-245X surname: Chung fullname: Chung, Joo Seop organization: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea – sequence: 7 givenname: Ihm Soo orcidid: 0000-0002-8022-9205 surname: Kwak fullname: Kwak, Ihm Soo organization: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28776339$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002256308$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9UkuP0zAQjtAi9gG_AAn5CIeG-Nn4glStFlqxCIQKV8t1Jq23id21naL-Av42TrusgAOnsTTfYzzzXRZnzjsoipe4Kill4u3dto8lqfC0pKSUJWaMPykuMJf1RFA-PcvvCuNJLSk7Ly5jvKsqwjmhz4pzUk-nglJ5UfxcBnBNRNahT7qza6edsRCR7r1bo48-gHboi04WXIpo4VowCRr0w6YNmg99bi76fnC-gdZmojMH9N2G4SiYNoDmdr3pDmhmkt0DmrlkA6Tg9zboDi03EPTugG6Cfl48bXUX4cVDvSq-vb9ZXs8nt58_LK5ntxPDqEyTVmuJxYqI_AFaNTXTANqwFWkhrwRLijVrhQC-kqxpa0YEbwHTCusVaFFRelW8Oem60Kqtscpre6xrr7ZBzb4uF4rwmnNRZ-y7E3Y3rHpoTF5Bnlrtgu11OByZf3ec3WSdveKcCSlGs9cPAsHfDxCT6m000HXagR-iwpIIUXMiZIa--tPr0eT3pTKAngAm-BgDtI8QXKkxD2rMgxrzoChRUo15yCz5D8vYlK_px4Ft91_uLyKuvxo |
CitedBy_id | crossref_primary_10_3947_ic_2019_51_1_35 crossref_primary_10_1038_s41598_022_14170_5 crossref_primary_10_1016_j_jiac_2022_04_015 crossref_primary_10_1177_23247096211065633 crossref_primary_10_1001_jamanetworkopen_2022_24897 crossref_primary_10_5812_archcid_98922 crossref_primary_10_1186_s12885_018_5019_9 crossref_primary_10_1016_j_jiac_2023_01_018 crossref_primary_10_1097_QAI_0000000000003389 |
Cites_doi | 10.1056/NEJM199803263381301 10.1016/S0140-6736(14)60604-8 10.1177/135965350200700103 10.3346/jkms.2016.31.2.178 10.1016/S0140-6736(04)16593-8 10.1097/01.qai.0000233310.90484.16 10.1097/QAD.0000000000000163 10.1097/01.aids.0000238411.75324.59 10.1038/sj.bjc.6605756 10.1002/cncr.27694 10.1002/ijc.25153 10.1097/01.qai.0000232260.95288.93 10.3346/jkms.2013.28.7.990 10.1001/jama.279.6.450 10.3346/jkms.2013.28.1.67 10.1002/ijc.23487 10.1097/QAI.0000000000000065 10.1016/S0140-6736(16)31012-1 10.1093/jnci/92.22.1823 10.1200/JCO.2012.44.5486 10.7326/0003-4819-148-10-200805200-00005 10.1001/archinte.165.4.416 10.1016/S0140-6736(08)61113-7 10.4167/jbv.2016.46.4.283 |
ContentType | Journal Article |
Copyright | 2017 The Korean Academy of Medical Sciences. 2017 The Korean Academy of Medical Sciences. 2017 |
Copyright_xml | – notice: 2017 The Korean Academy of Medical Sciences. – notice: 2017 The Korean Academy of Medical Sciences. 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ACYCR |
DOI | 10.3346/jkms.2017.32.9.1445 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1598-6357 |
EndPage | 1450 |
ExternalDocumentID | oai_kci_go_kr_ARTI_2585568 PMC5546963 28776339 10_3346_jkms_2017_32_9_1445 |
Genre | Journal Article |
GroupedDBID | --- 29K 2WC 3O- 5-W 53G 5GY 8JR 8XY 9ZL AAYXX ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION CS3 D-I DIK DU5 E3Z EBS EF. EJD F5P FRP GROUPED_DOAJ GX1 HYE KQ8 M48 O5R O5S OK1 OVT PGMZT RNS RPM TR2 W2D XSB CGR CUY CVF ECM EIF NPM 7X8 5PM 08R ACYCR M~E |
ID | FETCH-LOGICAL-c439t-faa916b2687730d84aeeac4b2fe3461931a4f66e5b94df84265fe1301abea6033 |
IEDL.DBID | M48 |
ISSN | 1011-8934 1598-6357 |
IngestDate | Tue Nov 21 21:43:56 EST 2023 Tue Sep 30 15:35:03 EDT 2025 Fri Jul 11 04:52:50 EDT 2025 Mon Jul 21 06:02:38 EDT 2025 Tue Jul 01 01:44:59 EDT 2025 Thu Apr 24 22:51:40 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | AIDS Malignancy HIV Antiretroviral Therapy |
Language | English |
License | 2017 The Korean Academy of Medical Sciences. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c439t-faa916b2687730d84aeeac4b2fe3461931a4f66e5b94df84265fe1301abea6033 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-7652-7093 0000-0002-8022-9205 0000-0002-5205-3978 0000-0002-4137-5453 0000-0003-3027-1381 0000-0003-2093-3628 0000-0001-7008-245X |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3346/jkms.2017.32.9.1445 |
PMID | 28776339 |
PQID | 1926685269 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_2585568 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5546963 proquest_miscellaneous_1926685269 pubmed_primary_28776339 crossref_primary_10_3346_jkms_2017_32_9_1445 crossref_citationtrail_10_3346_jkms_2017_32_9_1445 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-09-01 |
PublicationDateYYYYMMDD | 2017-09-01 |
PublicationDate_xml | – month: 09 year: 2017 text: 2017-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Journal of Korean medical science |
PublicationTitleAlternate | J Korean Med Sci |
PublicationYear | 2017 |
Publisher | The Korean Academy of Medical Sciences 대한의학회 |
Publisher_xml | – name: The Korean Academy of Medical Sciences – name: 대한의학회 |
References | Choe (10.3346/jkms.2017.32.9.1445_ref20) 2006; 38 Hogg (10.3346/jkms.2017.32.9.1445_ref2) 1998; 279 Polesel (10.3346/jkms.2017.32.9.1445_ref12) 2010; 127 Seol (10.3346/jkms.2017.32.9.1445_ref21) 2009; 76 (10.3346/jkms.2017.32.9.1445_ref23) 2008; 372 Lee (10.3346/jkms.2017.32.9.1445_ref4) 2013; 28 Chen (10.3346/jkms.2017.32.9.1445_ref9) 2014; 65 Mocroft (10.3346/jkms.2017.32.9.1445_ref5) 2002; 7 d’Arminio Monforte (10.3346/jkms.2017.32.9.1445_ref1) 2005; 165 Ruxrungtham (10.3346/jkms.2017.32.9.1445_ref8) 2004; 364 (10.3346/jkms.2017.32.9.1445_ref24) 2016; 388 Palella (10.3346/jkms.2017.32.9.1445_ref6) 2006; 43 Piketty (10.3346/jkms.2017.32.9.1445_ref11) 2012; 30 Brock (10.3346/jkms.2017.32.9.1445_ref17) 2006; 43 Robbins (10.3346/jkms.2017.32.9.1445_ref25) 2014; 28 Patel (10.3346/jkms.2017.32.9.1445_ref16) 2008; 148 Palella (10.3346/jkms.2017.32.9.1445_ref7) 1998; 338 (10.3346/jkms.2017.32.9.1445_ref14) 2000; 92 (10.3346/jkms.2017.32.9.1445_ref22) 1992; 41 Engels (10.3346/jkms.2017.32.9.1445_ref10) 2008; 123 Kang (10.3346/jkms.2017.32.9.1445_ref29) 2016; 31 Lee (10.3346/jkms.2017.32.9.1445_ref3) 2013; 28 Franceschi (10.3346/jkms.2017.32.9.1445_ref19) 2010; 103 Sahasrabuddhe (10.3346/jkms.2017.32.9.1445_ref13) 2012; 118 Smith (10.3346/jkms.2017.32.9.1445_ref26) 2014; 384 Lee (10.3346/jkms.2017.32.9.1445_ref27) 2016; 46 Mitsuyasu (10.3346/jkms.2017.32.9.1445_ref18) 2008; 16 10.3346/jkms.2017.32.9.1445_ref28 Engels (10.3346/jkms.2017.32.9.1445_ref15) 2006; 20 15738371 - Arch Intern Med. 2005 Feb 28;165(4):416-23 23853480 - J Korean Med Sci. 2013 Jul;28(7):990-7 18435450 - Int J Cancer. 2008 Jul 1;123(1):187-94 23341714 - J Korean Med Sci. 2013 Jan;28(1):67-73 18657708 - Lancet. 2008 Jul 26;372(9635):293-9 12008784 - Antivir Ther. 2002 Mar;7(1):21-30 9466638 - JAMA. 1998 Feb 11;279(6):450-4 16936558 - J Acquir Immune Defic Syndr. 2006 Sep;43(1):47-55 16868446 - AIDS. 2006 Aug 1;20(12):1645-54 23091098 - J Clin Oncol. 2012 Dec 10;30(35):4360-6 15234860 - Lancet. 2004 Jul 3-9;364(9428):69-82 16878047 - J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34 20049835 - Int J Cancer. 2010 Sep 1;127(6):1437-45 18490686 - Ann Intern Med. 2008 May 20;148(10):728-36 27733281 - Lancet. 2016 Oct 8;388(10053):1459-1544 20588274 - Br J Cancer. 2010 Jul 27;103(3):416-22 1361652 - MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19 25042234 - Lancet. 2014 Jul 19;384(9939):241-8 18838745 - Top HIV Med. 2008 Oct-Nov;16(4):117-21 24300545 - AIDS. 2014 Mar 27;28(6):881-90 24583616 - J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):463-72 22736272 - Cancer. 2012 Dec 15;118(24):6226-33 26839469 - J Korean Med Sci. 2016 Feb;31(2):178-82 11078759 - J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30 9516219 - N Engl J Med. 1998 Mar 26;338(13):853-60 |
References_xml | – volume: 338 start-page: 853 year: 1998 ident: 10.3346/jkms.2017.32.9.1445_ref7 publication-title: N Engl J Med doi: 10.1056/NEJM199803263381301 – volume: 76 start-page: 554 year: 2009 ident: 10.3346/jkms.2017.32.9.1445_ref21 publication-title: Korean J Med – volume: 384 start-page: 241 year: 2014 ident: 10.3346/jkms.2017.32.9.1445_ref26 publication-title: Lancet doi: 10.1016/S0140-6736(14)60604-8 – volume: 7 start-page: 21 year: 2002 ident: 10.3346/jkms.2017.32.9.1445_ref5 publication-title: Antivir Ther doi: 10.1177/135965350200700103 – volume: 31 start-page: 178 year: 2016 ident: 10.3346/jkms.2017.32.9.1445_ref29 publication-title: J Korean Med Sci doi: 10.3346/jkms.2016.31.2.178 – volume: 364 start-page: 69 year: 2004 ident: 10.3346/jkms.2017.32.9.1445_ref8 publication-title: Lancet doi: 10.1016/S0140-6736(04)16593-8 – volume: 43 start-page: 27 year: 2006 ident: 10.3346/jkms.2017.32.9.1445_ref6 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/01.qai.0000233310.90484.16 – volume: 38 start-page: 367 year: 2006 ident: 10.3346/jkms.2017.32.9.1445_ref20 publication-title: Infect Chemother – volume: 28 start-page: 881 year: 2014 ident: 10.3346/jkms.2017.32.9.1445_ref25 publication-title: AIDS doi: 10.1097/QAD.0000000000000163 – volume: 20 start-page: 1645 year: 2006 ident: 10.3346/jkms.2017.32.9.1445_ref15 publication-title: AIDS doi: 10.1097/01.aids.0000238411.75324.59 – volume: 103 start-page: 416 year: 2010 ident: 10.3346/jkms.2017.32.9.1445_ref19 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6605756 – volume: 41 start-page: 1 year: 1992 ident: 10.3346/jkms.2017.32.9.1445_ref22 publication-title: MMWR Recomm Rep – volume: 118 start-page: 6226 year: 2012 ident: 10.3346/jkms.2017.32.9.1445_ref13 publication-title: Cancer doi: 10.1002/cncr.27694 – volume: 127 start-page: 1437 year: 2010 ident: 10.3346/jkms.2017.32.9.1445_ref12 publication-title: Int J Cancer doi: 10.1002/ijc.25153 – volume: 16 start-page: 117 year: 2008 ident: 10.3346/jkms.2017.32.9.1445_ref18 publication-title: Top HIV Med – volume: 43 start-page: 47 year: 2006 ident: 10.3346/jkms.2017.32.9.1445_ref17 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/01.qai.0000232260.95288.93 – volume: 28 start-page: 990 year: 2013 ident: 10.3346/jkms.2017.32.9.1445_ref4 publication-title: J Korean Med Sci doi: 10.3346/jkms.2013.28.7.990 – ident: 10.3346/jkms.2017.32.9.1445_ref28 – volume: 279 start-page: 450 year: 1998 ident: 10.3346/jkms.2017.32.9.1445_ref2 publication-title: JAMA doi: 10.1001/jama.279.6.450 – volume: 28 start-page: 67 year: 2013 ident: 10.3346/jkms.2017.32.9.1445_ref3 publication-title: J Korean Med Sci doi: 10.3346/jkms.2013.28.1.67 – volume: 123 start-page: 187 year: 2008 ident: 10.3346/jkms.2017.32.9.1445_ref10 publication-title: Int J Cancer doi: 10.1002/ijc.23487 – volume: 65 start-page: 463 year: 2014 ident: 10.3346/jkms.2017.32.9.1445_ref9 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0000000000000065 – volume: 388 start-page: 1459 year: 2016 ident: 10.3346/jkms.2017.32.9.1445_ref24 publication-title: Lancet doi: 10.1016/S0140-6736(16)31012-1 – volume: 92 start-page: 1823 year: 2000 ident: 10.3346/jkms.2017.32.9.1445_ref14 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/92.22.1823 – volume: 30 start-page: 4360 year: 2012 ident: 10.3346/jkms.2017.32.9.1445_ref11 publication-title: J Clin Oncol doi: 10.1200/JCO.2012.44.5486 – volume: 148 start-page: 728 year: 2008 ident: 10.3346/jkms.2017.32.9.1445_ref16 publication-title: Ann Intern Med doi: 10.7326/0003-4819-148-10-200805200-00005 – volume: 165 start-page: 416 year: 2005 ident: 10.3346/jkms.2017.32.9.1445_ref1 publication-title: Arch Intern Med doi: 10.1001/archinte.165.4.416 – volume: 372 start-page: 293 year: 2008 ident: 10.3346/jkms.2017.32.9.1445_ref23 publication-title: Lancet doi: 10.1016/S0140-6736(08)61113-7 – volume: 46 start-page: 283 year: 2016 ident: 10.3346/jkms.2017.32.9.1445_ref27 publication-title: J Bacteriol Virol doi: 10.4167/jbv.2016.46.4.283 – reference: 15234860 - Lancet. 2004 Jul 3-9;364(9428):69-82 – reference: 27733281 - Lancet. 2016 Oct 8;388(10053):1459-1544 – reference: 23091098 - J Clin Oncol. 2012 Dec 10;30(35):4360-6 – reference: 22736272 - Cancer. 2012 Dec 15;118(24):6226-33 – reference: 20049835 - Int J Cancer. 2010 Sep 1;127(6):1437-45 – reference: 15738371 - Arch Intern Med. 2005 Feb 28;165(4):416-23 – reference: 16878047 - J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34 – reference: 18838745 - Top HIV Med. 2008 Oct-Nov;16(4):117-21 – reference: 12008784 - Antivir Ther. 2002 Mar;7(1):21-30 – reference: 24300545 - AIDS. 2014 Mar 27;28(6):881-90 – reference: 23341714 - J Korean Med Sci. 2013 Jan;28(1):67-73 – reference: 20588274 - Br J Cancer. 2010 Jul 27;103(3):416-22 – reference: 23853480 - J Korean Med Sci. 2013 Jul;28(7):990-7 – reference: 26839469 - J Korean Med Sci. 2016 Feb;31(2):178-82 – reference: 18657708 - Lancet. 2008 Jul 26;372(9635):293-9 – reference: 9516219 - N Engl J Med. 1998 Mar 26;338(13):853-60 – reference: 16868446 - AIDS. 2006 Aug 1;20(12):1645-54 – reference: 11078759 - J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30 – reference: 24583616 - J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):463-72 – reference: 9466638 - JAMA. 1998 Feb 11;279(6):450-4 – reference: 16936558 - J Acquir Immune Defic Syndr. 2006 Sep;43(1):47-55 – reference: 1361652 - MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19 – reference: 18490686 - Ann Intern Med. 2008 May 20;148(10):728-36 – reference: 25042234 - Lancet. 2014 Jul 19;384(9939):241-8 – reference: 18435450 - Int J Cancer. 2008 Jul 1;123(1):187-94 |
SSID | ssj0025523 |
Score | 2.1966698 |
Snippet | Since the introduction of highly active antiretroviral therapy, the life span of people with human immunodeficiency virus (HIV) or AIDS (PWHA) has been... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1445 |
SubjectTerms | Acquired Immunodeficiency Syndrome - complications Acquired Immunodeficiency Syndrome - diagnosis Adult Anti-Retroviral Agents - adverse effects Anti-Retroviral Agents - therapeutic use Antiretroviral Therapy, Highly Active - adverse effects Female HIV Infections - complications HIV Infections - drug therapy HIV Infections - pathology Homosexuality Humans Incidence Liver Neoplasms - diagnosis Liver Neoplasms - epidemiology Liver Neoplasms - etiology Liver Neoplasms - mortality Lung Neoplasms - diagnosis Lung Neoplasms - epidemiology Lung Neoplasms - etiology Lung Neoplasms - mortality Lymphoma, Non-Hodgkin - diagnosis Lymphoma, Non-Hodgkin - epidemiology Lymphoma, Non-Hodgkin - etiology Lymphoma, Non-Hodgkin - mortality Male Medication Adherence Middle Aged Neoplasms - diagnosis Neoplasms - epidemiology Neoplasms - etiology Neoplasms - mortality Original Republic of Korea - epidemiology Retrospective Studies Sarcoma, Kaposi - diagnosis Sarcoma, Kaposi - epidemiology Sarcoma, Kaposi - etiology Sarcoma, Kaposi - mortality Survival Rate Tertiary Care Centers 의학일반 |
Title | Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28776339 https://www.proquest.com/docview/1926685269 https://pubmed.ncbi.nlm.nih.gov/PMC5546963 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002256308 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Korean Medical Science, 2017, 32(9), 231, pp.1445-1450 |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1598-6357 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025523 issn: 1011-8934 databaseCode: KQ8 dateStart: 19860101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1598-6357 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025523 issn: 1011-8934 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals - Free Access to All customDbUrl: eissn: 1598-6357 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025523 issn: 1011-8934 databaseCode: DIK dateStart: 19860101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1598-6357 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025523 issn: 1011-8934 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 1598-6357 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025523 issn: 1011-8934 databaseCode: 5-W dateStart: 19860101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1598-6357 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025523 issn: 1011-8934 databaseCode: RPM dateStart: 19860101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1598-6357 dateEnd: 20250831 omitProxy: true ssIdentifier: ssj0025523 issn: 1011-8934 databaseCode: M48 dateStart: 19860901 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELbaIiEuiDfLIzKIIxtlvV6v94BQhFo1VEEcGtSbZWftEiV4281Gor-Av82MvYlaVDhw2kP2FY89841n9vsIeedcIYwrbOq4G6VcO5FWTMsU_KKuCqNZHTSWpl_E8Yx_PivO9shWFbUfwPWtqR3qSc3a1fDn5dVHWPAfMOPMsUK5_IHE21k5zNmwwnJlsU_uQGhiOM2nfFdWAPjMYsd9lqUQqHmkIfrbTZAoWJawAFFJ_FrU2vetuw2Q_tlXeS1QHT0g93uEScdxSjwke9Y_InenfQ39MfkV22DpwtMpgPDzqM-7pkF2iJ40gCI9_RrpVtd0Epq1bE1xw5aGLX86wW9Kmtoi-QR-uUm_LdpNuCGgSYqdI6srOg6OlI59B061w40LeFd6GkkM6GGrn5DZ0eHpp-O0l2NI54BautRpDVjSMAFjko9qybUFr80NcxYGEIBgprkTwham4rWTEPoLZyFEZtpYLUZ5_pQc-Mbb54QaXQOMcOU8E5K7TBojR7rMi9wAWsvKOiFsO9xq3nOVo2TGSkHOguZSaC6F5lI5U5VCcyXk_e6ii0jV8e_T34Id1XK-UEixjcfzRi1bBYnERDFIowohE_Jma2YF6w6LKdrbZrNWgIyFkKjPnpBn0ey7p25nTULKGxNidwI-8OYvfvE9cHtj0yD4xBf_feVLcg__Z2yDe0UOunZjXwNu6swAMobJySDsOgzCuvgNsCYZvg |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trends+in+Malignancies+among+Korean+Patients+Infected+with+Human+Immunodeficiency+Virus+in+the+Highly+Active+Antiretroviral+Therapy+Era&rft.jtitle=Journal+of+Korean+medical+science&rft.au=Lee%2C+Shinwon&rft.au=Lee%2C+Sun+Hee&rft.au=Lee%2C+Jeong+Eun&rft.au=Kang%2C+Jin+Suk&rft.date=2017-09-01&rft.pub=The+Korean+Academy+of+Medical+Sciences&rft.issn=1011-8934&rft.eissn=1598-6357&rft.volume=32&rft.issue=9&rft.spage=1445&rft.epage=1450&rft_id=info:doi/10.3346%2Fjkms.2017.32.9.1445&rft_id=info%3Apmid%2F28776339&rft.externalDocID=PMC5546963 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-8934&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-8934&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-8934&client=summon |